Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Top Cited Papers
Open Access
- 18 August 2004
- journal article
- review article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Pharmacological Reviews
- Vol. 56 (3), 387-437
- https://doi.org/10.1124/pr.56.3.3
Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) represent one of the most highly utilized classes of pharmaceutical agents in medicine. All NSAIDs act through inhibiting prostaglandin synthesis, a catalytic activity possessed by two distinct cyclooxygenase (COX) isozymes encoded by separate genes. The discovery of COX-2 launched a new era in NSAID pharmacology, resulting in the synthesis, marketing, and widespread use of COX-2 selective drugs. These pharmaceutical agents have quickly become established as important therapeutic medications with potentially fewer side effects than traditional NSAIDs. Additionally, characterization of the two COX isozymes is allowing the discrimination of the roles each play in physiological processes such as homeostatic maintenance of the gastrointestinal tract, renal function, blood clotting, embryonic implantation, parturition, pain, and fever. Of particular importance has been the investigation of COX-1 and -2 isozymic functions in cancer, dysregulation of inflammation, and Alzheimer's disease. More recently, additional heterogeneity in COX-related proteins has been described, with the finding of variants of COX-1 and COX-2 enzymes. These variants may function in tissue-specific physiological and pathophysiological processes and may represent important new targets for drug therapy.Keywords
This publication has 455 references indexed in Scilit:
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasThe New England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerThe New England Journal of Medicine, 2003
- Inhibition of Prostaglandin H2Synthases by Salicylate Is Dependent on the Oxidative State of the EnzymesThe Journal of pharmacology and experimental therapeutics, 2003
- Parecoxib (Parecoxib Sodium)Drugs, 2001
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Cyclo-Oxygenase-2 InhibitorsDrugs & Aging, 2000
- Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient MiceCell, 1997
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995
- Efficacy and Tolerability of Nimesulide in Asthmatic Patients Intolerant to AspirinDrugs, 1993
- Nimesulide Binding to Components within BloodDrugs, 1993